Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014-2015.
Samson M HaumbaMitsuru TodaRosanna Jeffries MazharPeter D EhrenkranzMunyaradzi PasipamireTrong AoNomthandazo G LukheleSikhathele MazibukoMandzisi MkhontfoRachel M SmithTom M ChillerPublished in: African journal of laboratory medicine (2020)
The prevalence of CrAg in Eswatini was higher than the current global estimate of 6% amongst HIV-positive people with CD4 < 100 cell/mm3, indicating the importance of initiating a national screening programme. Mechanisms for CrAg testing, training, reporting, and drug and commodity supply issues are important considerations before national implementation.
Keyphrases
- hiv positive
- men who have sex with men
- south africa
- antiretroviral therapy
- quality improvement
- end stage renal disease
- risk factors
- human immunodeficiency virus
- ejection fraction
- primary care
- chronic kidney disease
- healthcare
- hiv infected
- peritoneal dialysis
- single cell
- cell therapy
- prognostic factors
- adverse drug
- mesenchymal stem cells
- hepatitis c virus
- virtual reality
- electronic health record